ABSTRACT
Three patient's scores were suggestive of depression or anxiety; one had both depression and anxiety. Eight patients had mood disorders; three had a history of emotional abuse or neglect. PNES subsided in all patients within 1-3 months, only after withdrawl of LEV and did not recur in any after stopping LEV.
Conclusion
LEV can induce PNES in susceptible populations. Awareness of this association is crucial for timely withdrawal of triggering factor and appropriate management. This will reduce inadvertent additional prescription of antiepileptic agents.
Psychogenic non-epileptic seizure (PNES) is an observable abrupt paroxysmal change in behaviour or consciousness that are similar to an epileptic seizure, but not accompanied by changes in the electroencephalogram (EEG) that accompany an epileptic seizure. An epileptic seizure is a clinical diagnosis, based on the entirety of the clinical and para-clinical findings. Generally, positive evidence or strong suspicion for psychogenic factors that may have caused are noted in PNES. [1] [2] [3] Presence of an underlying personality disorder is suggested to be a significant predictor of the disease. 4 Emotional dysregulation, dissociations, abuse and cognitive disturbances are more frequently seen in patients with PNES. 5, 6 Use of levetiracetam (LEV) is increasing in the management of epilepsy. Though it has a better safety profile, physicians need to be aware of its consider-able association with behavioural changes, which may manifest as psychosis. 7, 8 A paradoxical effect of LEV with exacerbation of true seizures is well documented 9 but very few case reports of emergence of non-epileptic seizures are available. 10, 11 There is a high incidence of PNES in patients treated with LEV. In such patients, PNES could either be stopped, or reduced significantly after discontinuation of the drug along with supportive psychiatric treatment.
PNES is a condition where diagnosis is more challenging and delay in diagnosis may result in further addition of antiepileptic agents. Early diagnosis and withdrawal of precipitating drug is crucial in the management as under recognition may result in unwarranted investigations and treatment. In this study, we describe the occurrence of PNES in a cohort of patients with epilepsy while on LEV therapy and subsidence after the drug withdrawal.
METHODS

Patients
This prospective study was undertaken by the Department of Neurology, Nizams Institute of Medical Sciences, Hyderabad, India, a tertiary referral centre. The study group consisted of a series of patients diagnosed to have PNES causatively associated with LEV use, treated by a single neurologist between January 2015 and December 2015.
Diagnosis of PNES was as defined by LaFrance et al. 12 Patients were included if they had a definite past history of epilepsy and PNES documented by video electroencephalogram (VEEG) while receiving LEV either as a monotherapy or as an adjuvant with other antiepileptic drugs. Patients having a strong correlation between the onset of PNES during addition or recent increase in the dose of LEV and those in whom there was subsidence of PNES after discontinuation of LEV were also included. Patients with past history of psychiatric illness, PNES and those in whom detailed neuropsychological functions could not be performed were excluded.
All patients underwent VEEG, high-resolution magnetic resonance imaging (MRI), neuro-psychological and psychiatric evaluation. Details of seizure semiology of both true and PNES, including duration, type, medications, patient & family history, and clinical response to treatment (stoppage of LEV and psychiatric medications) were recorded. Detailed neuropsychological evaluation performed by clinical psychologist included Intelligence Quotient (IQ) assessment and Hamilton depression and anxiety stress scores (DASS). 13, 14 Weschler adult intelligence scale was administered for adults. 15 Malin's Intelligence Scale for Indian children, which is a validated Indian adaptation of Wechsler's Intelligence Scale for children, was used to assess the IQ of children. 16 Seven patients (patients 1-7, Group I) were treated by a psychiatrist and prescribed psychiatric medications (a combination of escitalopram or sertraline with clonazepam). LEV was gradually withdrawn over the ensuing two weeks.
A different strategy was applied to the next 8 patients (patients 8-13, Group II). These patients received psychiatric consultation for the initial two months along with anxiolytics but LEV was continued. After two months, LEV was gradually withdrawn. All patients were followed up for six months and monitored for relapse of PNES.
Assessments
Video Electroencephalography
All recordings were carried out on a 16-channel VEEG acquisition system (NicVue, Nicolet-Viking, USA) with the scalp electrodes placed according to the International10-20 system. VEEG was recorded for 40 minutes (20 minute awake and 20 minute sleep record), included 3 minutes of hyperventilation and photic stimulation in wakefulness. A partial sleep deprivation protocol was used. All patients with referral diagnosis of PNES underwent induction for precipitation of PNES with the help of a vibrating tunic fork. 17, 18 The distribution of interictal epileptiform discharges (IEDs) was assessed by visual analysis of EEG samples. The background activity was assessed for evidence of any focal slowing defined as the presence of localized slow waves not present in the other homotopic regions. IEDs were categorized as either diphasic/ triphasicsharp-wave/spike or a spike-wave complex pattern. Any activation of IEDs in sleep was noted.
The standard method of inducing a PNES was used in which patients were hypnotized using vibrating tuning fork. The EEG correlate was noted. These episodes were also confirmed with the patient family whether they were current habitual seizures. These PNES were classified using the standard classification.
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STATISTICAL ANALYSIS
Data was captured on Microsoft Excel 2007 worksheets and analyzed data was expressed as frequency, mean ± Standard Deviation (SD), percentage and range. Assessments and outcomes were explained using descriptive analysis.
RESULTS
We included 13 patients with LEV induced PNES. There were 11 females (86 %) and two males (14%). Mean (±SD) age of patients was 25.75 ± 12.28 years with a range of 12-54 years. Mean duration of true seizures was 10.77 ± 6.47 years, (range 1-22 years). The duration of PNES was short in all these patients with a mean of 7.66 ± 5.28 months (range 2-18 months).
PNES was classified using the Hubsch classification system. 19 Five (39%) patients each belonged to Class 3 and 4; There were one patient (7%) each in Class 1, Class 2 and Class 5 (Table1). In all these patients, PNES were frequent (daily in four patients) and manifested only when they were awake. None of these patients suffered injuries. All were subjected to 1.5 Tesla MRI brain scan and 11 (84.62%) demonstrated the respective abnormalities (Table  1) .
All received antiepileptic agents along with LEV. All were prescribed ≥1000mg/day except one patient who was using 500 mg/day of LEV (Table 2) . Mean dose of LEV received by our patients was 1269.23 ± 483.71mg/day.
Relationship to Levetiracetam Therapy
In group II, patients in whom LEV was continued for two months after the diagnosis of PNES, all continued to have PNES though psychiatric treatment was given. They had complete remission of PNES only after the withdrawal of LEV. Mean time taken for subsidence of PNES in group II was 1.08 (± 0.50) months, after discontinuation of LEV. In group 1, patients in whom LEV was withdrawn initially, after the diagnosis of PNES, there was resolution of PNES in 1 to 2 months, with mean of 1.57(± 0.5) months. There was no statistically significant difference (p>0.05) between the two groups.
Neuropsychological and Psychiatric Evaluation
All patients underwent a baseline psychiatric evaluation and a detailed neuropsychological assessment. IQ was normal in all except four patients (Table 3) .
Scores were suggestive of depression or anxiety in three (23.08%) patients and there was evidence of both depression and anxiety in one patient. Psychiatric assessment revealed mood disorder in eight (61.54%); history of emotional abuse or neglect was noted in three (23.08%) patients. Psychiatric evaluations were normal in five (38.46%) patients (Table 3 ). All 13 patients were followed up for 6 months after subsidence of PNES. We observed that after withdrawal of LEV, PNES subsided in all patients; none of them had reemergence of PNES after subsidence.
DISCUSSION
PNES is an under reported condition due to difficulty in differentiating from epileptic seizures and a high index of clinical suspicion supported by VEEG is essential for the confirmation of diagnosis. 20 Reported cases represent only the tip of the iceberg. Its incidence is estimated to be 0.91/100,000 per annum. 20 The proportion of patients suffering from epilepsy and PNES ranges from 5-20% in outpatient setting and 10-40% in hospitalized. [20] [21] [22] [23] [24] Treatment outcome depends not only on the age, early diagnosis, severity of associated psychological co-morbidites, but also on the management and longterm follow-up. 25 , 26 Chabolla et al 27 described the characteristic features of PNES, diagnostic features and identified the favourable factors influencing therapeutic outcome. They concluded In our study, females (86%) outnumbered males. Mean age of our patients was 25.75 years with a range of 12-54 years. Our patients had a long duration of true seizures with a mean of 10.77years (range 1-22 years) suggesting that PNES can occur at any stage of epilepsy. Interestingly, an incidental observation was that the duration of PNES was short in all our patients with a mean of 7.66 months (range 2-18 months).
All our patients were receiving >1000 mg/day LEV, except one on 500 mg/day. Mean dose of LEV was 1269.23 mg/day in our patients. This observation suggests that PNES is often associated with higher doses >1000 mg/day of LEV. We followed Hubsch clas-sification system to classify PNES. We had all types of patients with more number of patients with Class 3 and Class 4 (n=5, 39 %). In all our patients PNES manifested only when they were awake and none of these patients suffered injuries. We suspected PNES in 69% patients from history, and confirmed the same on VEEG, while in the others remaining it was diagnosed only during recording. This supports the diagnostic role of VEEG in PNES. It predicts the occurrence of PNES more precisely in females (86% vs 61%). 28 Though studies on PNES show female predominance O'Sullivan et al observed male affliction in their study. 21 Though mean age of occurrence of PNES is 3 rd decade, there have been reports wherein the higher age group between 34 and 39 years is affected. [29] [30] [31] We grouped our patients into two, to compare the therapeutic effect after withdrawal of the drug and confirm whether any other intervention can cause a subsidence of PNES without LEV tapering. Our patients in group II had complete remission of PNES only after the withdrawal of LEV, and continuation of psychiatric medications. This observation indicates the positive role of LEV in PNES in our patients.
Neuropsychological and psychiatric evaluation revealed association of depression and/or anxiety in these patients and associated mood disorder. History of emotional abuse or neglect was also seen in these patients. These revelations indicate the importance of these tests in identifying the subset of patients who are more liable to manifest PNES.
Underlying pathophysiology of PNES still remains unclear. Many psychosocial factors and psychological mechanisms have been found to be responsible for PNES, 23, 32 which indicate the significance of psychological assessment. 33 There is a strong association of multiple psychiatric conditions with PNES, 20 as seen in our patients.
There is an established positive relationship between shorter duration of consumption, number of antiepileptic drugs and the incidence of PNES 34 ; all of our patients were receiving multiple antiepileptic drugs, along with LEV. In the recent past there is increasing evidence on the behavioural side effects of LEV that are dose dependent. 7, 8 The onset of PNES was associated with the addition/increase in the dose of LEV as an antiepileptic agent in all our patients. This was the initial reason to suspect LEV as the offender. Subsidence of seizures after withdrawing the drug indicates the role of LEV in inducing PNES. In addition, none of these patients had recurrences and after the withdrawal of LEV, an observation that supports the positive association of PNES in these patients with LEV use.
The paradoxical ability of antiepileptic drugs to increase seizure activity has been recognized for decades. This may occur as a result of two separate mechanisms: (i) involving a nonspecific manifestation of drug intoxication; seizure worsening in this context is usually reversible by dosage reduction or elimination of unnecessary polypharmacy, (ii) a distinct adverse primary action of the drug in specific seizure types or in syndromic forms. 34, 35 These have been detailed in Table 4 .
Possible mechanisms underlying LEV induced behavioural disorders are idiosyncratic, dose-unrelated drug effects, dose related toxicity due to its unique mechanism of action and alternative psychoses (or behavioural disturbances) associated with the phenomenon of forced normalization. 10 Galimberti et al. 36 suggested a multifactorial role in the development of PNES LEV acts as a trigger point in those with predisposing psychiatric disorders in precipitating PNES. In our series, there were five patients in whom psychiatric and neuropsychological evaluations were completely normal. Thus, the mechanism still remains elusive and requires more investigation. Of the approved therapies, psychotherapy has proved to be the most effective (92.2%), while education (75%) and psychopharmacotherpay (70.3%) were next in the order. 17 LaFrance et al 29 in their multi-centric analysis observed reduction in seizure occurrence along with improvement in psychological functions, supporting the role of psychotherapy in the management. Brown et al 37 too advised psychotherapy in the management of PNES. Hence, we followed the standard treatment protocol of psychotherapy in both groups along with psychiatric medications and observed good therapeutic outcome.
Our study supports the positive association between LEV use and PNES; identifying the association, timely withdrawal of the medication, administering psychiatric treatment will result in better clinical outcome.
To the best of our knowledge this is the first case series of LEV associated PNES; there have been isolated single case reports. 10, 11 A good constellation of cases with strict inclusion criteria, would provide a stronger evidence for the positive association between the drug and PNES.
CONCLUSION
LEV can induce PNES in susceptible population. Multiple antiepileptic drugs with high dosage are the risk factors. Physician should be aware of this malady; timely withdrawal of the drug followed by appropriate psychotherapy is essential for recovery. Before escalating to higher dose of antiepileptic drugs, drug-induced PNES should be considered in the differential diagnosis to avoid unnecessary pill burden.
